Open·Ingested 45 days ago, not re-verified since

DoW Neurofibromatosis Exploration-Hypothesis Development Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: Jun 25, 2026
Amount: $1,280,000
Closes: Sep 22, 2026 (in 43 days)

Similar opportunities open now

DoW Neurofibromatosis Investigator-Initiated Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 43 days
DoW Multiple Sclerosis Exploration-Hypothesis Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 3 days
DoW Autism Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 73 days
DoW Autism Clinical Trial AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 73 days
DoW Autism Career Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 73 days

Classification and identifiers

Solicitation number: HT942526NFRPEHDA
Assistance listing (CFDA): 12.420

Amount

$1,280,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. Distinctive Features: • Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities. • Preli...